Journals / Bezmiâlem Science / 2020 / Cilt: 8 - Sayı: 2

Relationship between ABO Blood Group and COVID-19: TheCase of Siirt

ABO Kan Grubu ve COVID-19 Arasındaki İlişki: Siirt Örneği

Pages
36–40
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Combining the results of this study with data from other regions, it is thought that only if the relationship between blood group COVID-19 can be confirmed, it may be a guide for diagnosis, follow-up and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Epidemiological and clinical studies have shown that age and chronic diseases are important risk factors in the mortality of patients infected by Coronavirus disease 2019 (COVID-19).
📊
Key Findings & Data:Some studies have reported that ABO blood groups are associated with a predisposition to Covid-19.
💡
Conclusion & Impact:Combining the results of this study with data from other regions, it is thought that only if the relationship between blood group COVID-19 can be confirmed, it may be a guide for diagnosis, follow-up and treatment.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Epidemiological and clinical studies have shown that age and chronic diseases are important risk factors in the mortality of patients infected by Coronavirus disease 2019 (COVID-19). However, there is no biomarker identified yet for susceptibility to the disease. Some studies have reported that ABO blood groups are associated with a predisposition to Covid-19. In this study, it was aimed to investigate the relationship between ABO blood groups and COVID-19 susceptibility in Siirt province scale.Methods: In this study, the blood groups of 174 patients, all of whom were in Siirt, were confirmed retrospectively at the Siirt State Hospital, all confirmed by revers-transcriptase chain reaction. For comparison, data from 36394 patients whose blood group was detected in the Siirt State Hospital were used.Results: In Siirt provincial normal population; while blood groups A, B, AB and O were 40%, 19.5%, 8.5% and 32% respectively, the blood groups of COVID-19 positive patients were 42.5%, 19.5%, 8%, and 30%. No statistically significant difference was found in blood group distribution rates between healthy and COVID-19 patient groups (>0.05). The distribution of blood group rates of patients hospitalized in the intensive care unit was not different from healthy individuals (>0.05). No significant difference could be calculated between the duration of hospitalization in the intensive care unit and blood groups.Conclusion: As a result, unlike studies showing that the risk of COVID-19 infection was higher in the A blood group and lower in the O blood group, no relationship was found between the blood group and the risk of COVID-19 infection and intensive care therapy. Combining the results of this study with data from other regions, it is thought that only if the relationship between blood group COVID-19 can be confirmed, it may be a guide for diagnosis, follow-up and treatment.

Özet

Amaç: Epidemiyolojik ve klinik çalışmalar, Coronavirus hastalığı2019 (COVID-19) ile enfekte olan hastaların mortalitesinde yaşve kronik hastalıkların önemli risk faktörü olduğunu göstermiştir.Bununla birlikte hastalığa yatkınlık için henüz tanımlanmış birbiyolojik belirteç bulunmamaktadır. Yapılan bazı çalışmalar ABOkan gruplarının COVID-19’a yatkınlıkla ilişkili olduğu bildirmiştir.Bu çalışmada Siirt il ölçeğinde ABO kan grupları ile COVID-19yatkınlığı arasındaki ilişkinin araştırılması amaçlanmıştır. Yöntemler: Bu çalışmada Siirt Devlet Hastanesinde tümügerçek zamanlı polimeraz zincir reaksiyonu ile doğrulanmıştamamı Siirt’li olan 174 hastanın kan grupları retrospektif olarakdeğerlendirilmiştir. Karşılaştırma için Siirt Devlet Hastanesinde kangrubu tespiti yapılan 36.394 hastaya ait veriler kullanılmıştır. Bulgular: Siirt il geneli normal popülasyonda; A, B, AB ve O kangrupları sırasıyla %40, %19,5, %8,5 ve %32 iken COVID-19pozitif hastaların kan grupları sırasıyla; %42,5, %19,5, %8, %30bulunmuştur. Sağlıklı ve COVID-19 hasta grupları arasında kangrubu dağılım oranları arasında istatistiksel olarak anlamlı bir farkbulunmamıştır (>0.05). Yoğun bakım ünitesinde yatan hastalarınkan grubu oranlarındaki dağılım da sağlıklı bireylerden farklıbulunmamıştır (>0.05). Yoğun bakımdaki yatış süresi ile kangrupları arasında da anlamlı bir fark hesaplanamamıştır.Sonuç: Sonuç olarak, COVID-19 enfeksiyonu riskinin A kangrubunda daha yüksek, 0 kan grubunda daha düşük olduğunugösteren çalışmaların aksine kan grubuyla COVID-19 enfeksiyonriski ve yoğun bakım tedavisi arasında bir ilişki bulunmamıştır. Bu çalışmadaki sonuçların, diğer bölgelerdeki verilerle birleştirilmesiylekan grubu COVID-19 arasındaki ilişki doğrulanabildiğitakdirde ancak tanı, takip ve tedaviye yol gösterici olabileceğidüşünülmektedir.

🔖

Cite This Article

ÖZÜDOĞRU, O., ÜYÜKLÜ, M. (2022). Relationship between ABO Blood Group and COVID-19: TheCase of Siirt. Bezmiâlem Science, Cilt: 8 - Sayı: 2, 36–40. https://ajindex.com/articles/464021

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265-9
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506
  3. Chan JF, Yuan S, Kok KH, To KKW, Chu H, Yang J. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23 4. Calhoun L, Petz LD. Erythrocyte antigens and antibodies. In: Williams Hematology. Beutler E, Lichtman MA, Coller BS and Kipps TJ (eds) Fifth edition, New York, McGraw-Hill, 1995:1595
  4. Lesky E. Viennese serological research about the year 1900: its contribution to the development of clinical medicine. Bull N Y Acad Med 1973;49:100-11
  5. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998;38:975-88
  6. Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006;46:1836-44
  7. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-8
  8. Whincup PH, Danesh J, Walker M, Lennon L, Appleby P, Rumley A, et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002;23:1764-70
  9. Chen Y, Chen C, Ke X, Xiong L, Shi Y, Li J, et al. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 2014;7:43-8
  10. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol 2020
  11. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. MedRxiv 2020
  12. Goker H, Aladag KE, Demiroglu H, Ayaz CM, Buyukasik, Y, Inkaya AC, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 2020;50:679-83
  13. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends 2020;14-1:72-3
  14. Zhou D, Dai SM and Tong Q. COVID-19: a recommendatio